COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,557 Articles (22,400 medRxiv, 8,157 bioRxiv)

Most recent first Previous |  Page 2617: Articles 26161-26170  | Next

Combining PCR and CT testing for COVID
Shen, C., Mark, R., Kagetsu, N. J., Becker, A. S., Bar-Yam, Y.
10.1101/2020.05.27.20114736 — Posted: 2020-05-29
A pilot study to investigate the fecal dissemination of SARS-CoV-2 virus genome in COVID-19 patients in Odisha, India
Senapati, S., Kshatri, J. S., Prasad, P., Turuk, J., Pati, S., Parida, A.
10.1101/2020.05.26.20113167 — Posted: 2020-05-29
Mortality reduction in 46 severe Covid-19 patients treated with hyperimmune plasma. A proof of concept single arm multicenter interventional trial
Perotti, C., Baldanti, F., Bruno, R., Delfante, C., Seminari, E., Casari, S., Percivalle, E., Glingani, C., Musella, V., Belliato, M., Garuti, M., Meloni, F., Frigato, M., Di Sabatino, A., Klersy, C., De Donno, G., Franchini, M.
10.1101/2020.05.26.20113373 — Posted: 2020-05-29
Forecasting the Spread of COVID-19 under Different Reopening Strategies
Liu, M., Thomadsen, R., Yao, S.
10.1101/2020.05.26.20113993 — Posted: 2020-05-29
Correlation of population mortality of COVID-19 and testing coverage: a comparison among 36 OECD countries and Taiwan
Chen, W., Lee, C.-C., Hsu, T.-C., Hsu, W.-T., Chan, C.-C., Chen, S.-C., Chen, C.-J.
10.1101/2020.05.27.20113969 — Posted: 2020-05-29 Discussion: Onsite
A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding
Byrnes, J. R., Zhou, X. X., Lui, I., Elledge, S. K., Glasgow, J. E., Lim, S. A., Loudermilk, R., Chiu, C. Y., Wilson, M. R., Leung, K. K., Wells, J. A.
10.1101/2020.05.27.20114652 — Posted: 2020-05-29
Variation in Covid-19 Cases Across New York City
Federgruen, A., Naha, S. R.
10.1101/2020.05.25.20112797 — Posted: 2020-05-29
Modelling the thermal inactivation of viruses from the Coronaviridae family in suspensions or on surfaces with various relative humidities.
Guillier, L., Martin-Latil, S., Chaix, E., Thebault, A., Pavio, N., Le Poder, S., Batejat, C., Biot, F., Koch, L., Schaffner, D., Sanaa, M.
10.1101/2020.05.26.20114025 — Posted: 2020-05-29
COVID-19 in Multiple Sclerosis Patients and Risk Factors for Severe Infection
Chaudhry, F., Bulka, H., Rathnam, A. S., Said, O. M., Lin, J., Lorigan, H., Bernitsas, E., Rube, J., Korzeniewski, S. J., Memon, A. B., Levy, P. D., Javed, A., Lisak, R., Cerghet, M.
10.1101/2020.05.27.20114827 — Posted: 2020-05-29
Study protocol for COvid-19 Vascular sERvice (COVER) study: The impact of the COVID-19 pandemic on the provision, practice and outcomes of vascular surgery
Vascular and Endovascular Research Network, , Benson, R. A., Bosanquet, D. C., Nandhra, S., Shalhoub, J., Saratzis, A., Forsythe, R., Onida, S., Dovell, G., Hitchman, L., Dattani, N., Preece, R., Ambler, G. K., Imray, C.
10.1101/2020.05.27.20114322 — Posted: 2020-05-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).